ArticleOphthalmology science
Association between Plasma Metabolite Levels and Myopia: A 2-Sample Mendelian Randomization Study.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mendelian Randomization Studies of Myopia: Choosing the Right Summary Statistics.Investigative ophthalmology & visual science · 2025Article
- IMI-Myopia Genetics Report.Investigative ophthalmology & visual science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The role of plasma metabolites in myopia is still unclear, and previous studies are limited by various factors and were mostly observational. This study aims to investigate the causal relationship between plasma metabolites and myopia using 2-sample Mendelian randomization (MR). Design: A 2-sample MR study. Subjects and Participants: This study analyzed plasma metabolites consisting of 1091 metabolites and 309 metabolite ratios in 8299 individuals from the Canadian Longitudinal Study on Aging cohort. Summary statistics for myopia were obtained from the UK Biobank, encompassing 37 362 cases and 460 536 controls. Methods: Causal effect estimates were primarily derived using the inverse variance weighting (IVW) method and the constrained maximum likelihood and model averaging-based MR method. Statistical significance for the MR effect estimate was defined as a false discovery rate (FDR) of <0.05. Additionally, we used the MR Steiger directionality test to examine whether exposure was directionally causal for the outcome. Furthermore, 4 supplementary methods were used for analysis: weighted median, MR-Egger, simple mode, and weighted mode. Main Outcome Measures: Genetic causal association between plasma metabolites and myopia. Results: The IVW analysis results indicated that elevated levels of 1-arachidonoyl-GPE (20:4n6) (P_FDR = 5.80E-06), linoleoyl-arachidonoyl glycerol (18:2/20:4)[1] (P_FDR = 2.24E-06), and linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2](P_FDR = 0.0242) have a protective effect on myopia. Elevated levels of 4 plasma metabolite ratios, including the phosphate to linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] ratio (P_FDR = 0.0029), citrulline to dimethylarginine (SDMA + ADMA) ratio (P_FDR = 0.0207), oleoyl-linoleoyl-glycerol (18:1/18:2) [2] to linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] ratio (P_FDR = 0.0230), and retinol (vitamin A) to linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] ratio (P_FDR = 0.0230), were significantly associated with a higher risk of myopia. Conclusions: This study provides evidence of a causal relationship between specific plasma metabolites and myopia, highlighting potential therapeutic targets and contributing to the understanding of myopia's etiology. Future research should include diverse populations to enhance the generalizability of these findings. Financial Disclosures: The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.